Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2531798017 | Natalizumab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2535354010 | Natalizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3524446011 | Product containing natalizumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3524447019 | Product containing natalizumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3667763017 | Natalizumab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3715878019 | Natalizumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Natalizumab-containing product | Is a | Immunomodulator-containing product | true | Inferred relationship | Some | ||
| Natalizumab-containing product | Is a | Alpha-4 integrin receptor antagonist-containing product | true | Inferred relationship | Some | ||
| Natalizumab-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Natalizumab-containing product | Has active ingredient | Natalizumab | true | Inferred relationship | Some | 1 | |
| Natalizumab-containing product | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Some | ||
| Natalizumab-containing product | Is a | Murine-human monoclonal immunoglobulin G antibody product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Natalizumab-containing product in parenteral dose form | Is a | True | Natalizumab-containing product | Inferred relationship | Some | |
| Natalizumab only product | Is a | True | Natalizumab-containing product | Inferred relationship | Some | |
| Natalizumab 300mg injection solution 15mL vial | Is a | False | Natalizumab-containing product | Inferred relationship | Some | |
| Natalizumab 300 mg/15 mL solution for injection vial | Is a | False | Natalizumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR